Trial Profile
A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity of Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- 10 Jul 2017 New trial record